Parkman Healthcare Partners LLC
Q3 2025 13F Holdings
- Locationstamford, CT
- Num holdings
91
- Value ($000)
$958,704
- Date Filed 11/14/2025
- Form type13F-HR
- CIK 0001777015
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
N INVESCO QQQ TR | UNIT SER 1 | 46090E103 | $48.03M | 5 % | 80,000 | put | |
B BOSTON SCIENTIFIC CORP | COM | 101137107 | $42.41M | 4 % | 434,377 | ||
A ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | $39.99M | 4 % | 87,690 | ||
P INSULET CORP | COM | 45784P101 | $35.89M | 4 % | 116,238 | ||
C CVS HEALTH CORP | COM | 126650100 | $28.61M | 3 % | 379,486 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | $26.08M | 3 % | 671,592 | ||
V VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | $24.91M | 3 % | 1,154,487 | ||
Z ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | $24.76M | 3 % | 251,420 | ||
S STRYKER CORPORATION | COM | 863667101 | $23.70M | 3 % | 64,108 | ||
QIAGEN NV | COM SHS | N72482206 | $22.35M | 2 % | 500,159 |
Rows Per Page
10
- 10
- 50
- 100